Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic
J Antimicrob Chemother
.
2021 Jan 1;76(1):272-275.
doi: 10.1093/jac/dkaa400.
Authors
Ellen Martin
1
,
Marie Philbin
1
,
Gerry Hughes
2
3
,
Colm Bergin
2
3
,
Alida Fe Talento
4
5
6
Affiliations
1
Antimicrobial Resistance and Infection Control Division of HPSC, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
2
Department of Infectious Diseases, St James's Hospital, James's Street, Dublin 8, Ireland.
3
School of Medicine, Trinity College Dublin, College Green, Dublin 2, Ireland.
4
Department of Clinical Microbiology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland.
5
Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
6
Department of Clinical Microbiology, Royal College of Surgeons Ireland, Dublin, Ireland.
PMID:
33011763
PMCID:
PMC7665520
DOI:
10.1093/jac/dkaa400
No abstract available
Publication types
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Antimicrobial Stewardship*
COVID-19*
Drug Resistance, Bacterial
Hospitals
Humans
Pandemics
SARS-CoV-2
Substances
Anti-Bacterial Agents